Solriamfetol, a new treatment for ADHD, showed a 45% reduction in symptoms in a Phase 3 trial. This treatment targets ...

In this episode of Teach Me in 10, Ken Neubauer, Principal Application Scientist at PerkinElmer, explains how ICP-OES is used ...

Heart failure patients face significant cognitive decline, aging mentally by 10 years in seven. The study emphasizes the need ...

A study found 19 types of microplastics in the placentas and fetuses of pregnant cats, suggesting potential risks of plastic ...

A recent randomized control trial posits arginine depletion as a viable alternative to current systemic treatments based on ...

Researchers have developed fungal mycelium-based tiles that are more energy efficient than conventional building insulation ...

Our brain cells have different types of chemical receptors that work together to produce optimal performance of brain ...

A new organoid model reveals details of the developing nervous system’s response to viral infections, such as Rubella. It ...

A new study has uncovered a surprising role for calcium in shaping life’s earliest molecular structures, shedding light on ...

Researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, ...

Rather than warming the climate, the eruption of underwater volcano Hunga Tonga–Hunga Haʻapai in 2022 actually reduced ...

A Northwestern University-led study identifies brain regions that influence political passion, using veterans with and ...